Clinical Trial Update: EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction [NA]

View source ↗

Summary

This clinical trial evaluated EG-VEGF as a potential biomarker for pre-eclampsia and intrauterine growth restriction. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction
• Pre-eclampsia

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Pre-eclampsia, Intra-uterine Growth Retardation | NA | Status: COMPLETED